Evommune (EVMN) Other Non-Current Assets (2024 - 2026)

Evommune (EVMN) has 3 years of Other Non-Current Assets data on file, last reported at $73000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 64.9% year-over-year to $73000.0 in Q1 2026; TTM through Mar 2026 was $73000.0, a 64.9% decrease from a year earlier, with the FY2025 full-year figure at $101000.0, down 51.44% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $73000.0, down from $101000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for EVMN reached as high as $1.4 million in Q3 2025 and fell as low as $73000.0 in Q1 2026.
• Historically, Other Non-Current Assets has averaged $368333.3 across 3 years, with a median of $208000.0 in 2024.
• Across the five-year window, Other Non-Current Assets soared 578.85% in 2025 and plunged 64.9% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $208000.0 in 2024, then slumped by 51.44% to $101000.0 in 2025, then slipped by 27.72% to $73000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $73000.0 in Q1 2026, $101000.0 in Q4 2025, and $1.4 million in Q3 2025.